Pfizer Inc. Stock
€21.19
Your prediction
Pfizer Inc. Stock
Pros and Cons of Pfizer Inc. in the next few years
Pros
Cons
Performance of Pfizer Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 0.710% | 0.190% | -5.289% | -3.751% | -1.128% | -35.062% | -36.502% |
| BioMarin Pharmaceutical Inc. | 0.460% | 2.832% | 6.585% | 5.680% | 2.711% | -32.594% | -25.336% |
| Biogen Inc. | -0.950% | -5.007% | 4.907% | 52.833% | 16.984% | -30.104% | -43.751% |
| Zoetis Inc. A | -0.060% | 3.141% | -3.892% | -51.196% | -38.823% | -56.917% | -60.505% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When diving into the financials of Pfizer Inc. (PFE), a major player within the pharmaceuticals industry, a mixed picture starts to emerge. On the one hand, the company boasts a solid revenue stream and demonstrates a commendable operating margin, creating an impression of profitability. On the other hand, several warning signs appear in the form of declining growth metrics and concerns over income stability. Now, let’s break down the analysis into pros and cons to provide a comprehensive view.
Strong Revenue Performance: Pfizer reported a total revenue of approximately $54.89 billion over the trailing twelve months. This figure suggests that the company has maintained a robust sales figure, driven largely by their pharmaceutical portfolio, including well-known products and newly developed vaccines.
Healthy Operating Margins: The operating margin, standing at around 31.63%, illustrates the company's efficiency in turning sales into profit. This is relatively strong for the pharmaceutical sector, indicating that Pfizer is effectively managing its operating expenses relative to its revenue.
Comments
News
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
Dividend investing is a proven way to earn above-average long-term returns. That's why top dividend stocks often attract large crowds of investors and trade at a premium. However, it's possible to
Opinion: Pfizer's Dividend Is Riskier Than You Might Think
It's hard not to love high dividend yields. Who doesn't want more dividends for their money? Pfizer (NYSE: PFE) and its current yield of 7% will certainly grab your attention.
But remember that the
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant
Pfizer's (NYSE: PFE) shares have significantly underperformed broader equities over the past three years. The company's reliance on its coronavirus portfolio has been a weakness, as vaccination